BioCentury
ARTICLE | Finance

Quebec engine

Biotech VC Sanderling taps Gemin X management, sets up Therillia in Canada

September 23, 2013 7:00 AM UTC

Drawn by an experienced management team and the low cost of doing business in Montreal, Sanderling Ventures launched Therillia Development Co. Inc. to manage early stage development of assets to be funded by a newly formed Canadian fund.

Sanderling secured $30 million this month from BDC Venture Capital and Fonds de solidarite FTQ for the Canadian fund that Sanderling said will be part of its Sanderling VII fund, which is targeting $250 million...